Gastroesophageal reflux disease (GERD) is one of the most frequent gastrointestinal
disorders. Proton pump inhibitors (PPIs) are effective in healing lesions and improving …

Gastroesophageal reflux disease has an increasing incidence and prevalence worldwide. A
significant proportion of patients have a suboptimal response to proton pump inhibitors or …

Objectives Anti‐reflux mucosectomy (ARMS) and anti‐reflux mucosal ablation (ARMA) were
developed as interventions for proton pump inhibitor (PPI)‐refractory/‐dependent …

Background: Endoscopic treatments are increasingly being offered for refractory
gastroesophageal reflux disease (GERD). Three procedures have similar concepts and …

Background and study aims Anti-reflux mucosectomy (ARMS) is an emerging endoscopic
treatment for refractory gastroesophageal reflux disease (GERD). We conducted a …

Background and study aims Antireflux mucosectomy (ARMS) and antireflux mucosal
ablation (ARMA) are new endoscopic procedures for patients with gastroesophageal reflux …

Gastroesophageal reflux disease (GERD) is a common disorder, and empirical proton pump
inhibitor (PPI) treatment is often the first step of management; however, up to 40% of patients …

Background Currently, antireflux mucosectomy (ARMS) and Stretta radiofrequency (SRF)
are the most commonly used minimally invasive antireflux therapies. To date, there have not …

Background Anti-reflux mucosal intervention (ARMI), including anti-reflux mucosectomy
(ARMS) and anti-reflux mucosal ablation (ARMA), is a promising endoscopic treatment for …

Background Although some kinds of endoluminal surgery for patients with proton pump
inhibitor (PPI)-refractory gastroesophageal reflux disease (GERD) have been reported, there …